The effectiveness of edrophonium in 12 patients with supraventricular tachyarrhythmias.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001145:Arrhythmias, Cardiac / Q000188:drug therapy* / Q000209:etiology; D002648:Child; D002675:Child, Preschool; D004491:Edrophonium / Q000009:adverse effects / Q000627:therapeutic use; D004562:Electrocardiography; D005260:Female; D006331:Heart Diseases / Q000150:complications; D006801:Humans; D008297:Male; D008875:Middle Aged; D003473:Neuromuscular Nondepolarizing Agents / Q000037:antagonists & inhibitors*; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use*
D003473:Neuromuscular Nondepolarizing Agents; D000644:Quaternary Ammonium Compounds; D004491:Edrophonium